Yoichi Takakusagi Selected Research

Yoichi Takakusagi Research Topics

Disease

22	Neoplasms (Cancer) 10/2022 - 11/2005
4	Hypoxia (Hypoxemia) 01/2018 - 01/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2015 - 09/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Colonic Neoplasms (Colon Cancer) 11/2015
1	Adenocarcinoma 01/2015
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Autoimmune Diseases (Autoimmune Disease) 01/2013
1	Rheumatoid Arthritis 01/2013
1	Fanconi Anemia (Fanconi's Anemia) 11/2012

Drug/Important Bio-Agent (IBA)

7	Oxygen (Dioxygen)IBA 10/2022 - 01/2014
6	Pyruvic Acid (Pyruvate)IBA 01/2018 - 01/2014
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 02/2008
4	ProdrugsIBA 01/2018 - 01/2014
4	TH 302IBA 01/2018 - 01/2014
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2018 - 09/2014
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2014
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 11/2012
3	Pharmaceutical PreparationsIBA 12/2020 - 11/2005
2	isophosphamide mustard (IPAM)IBA 01/2018 - 01/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018 - 11/2015
2	Tamoxifen FDA LinkGeneric 09/2015 - 01/2013
2	CamptothecinIBA 12/2011 - 11/2005
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2011 - 11/2005
2	GemininIBA 03/2008 - 02/2008
2	Small Interfering RNA (siRNA)IBA 03/2008 - 02/2008
1	Thromboplastin (Tissue Factor)IBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2020
1	Oseltamivir (Tamiflu)FDA Link 12/2020
1	Peptides (Polypeptides)IBA 12/2020
1	Gadolinium DTPA (Magnevist)FDA Link 12/2018
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 12/2018
1	Oxyhemoglobins (Oxyhemoglobin)IBA 12/2018
1	NitroimidazolesIBA 01/2018
1	GadoliniumIBA 01/2018
1	dendronIBA 01/2018
1	Contrast MediaIBA 01/2018
1	Liposomes (Liposome)IBA 01/2018
1	Gemcitabine FDA Link 01/2018
1	Protons (Proton)IBA 01/2018
1	EnzymesIBA 01/2016
1	ridaifen GIBA 09/2015
1	RoxithromycinIBA 01/2015
1	MacrolidesIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 09/2014
1	Sunitinib (Sutent)FDA Link 09/2014
1	nitroxylIBA 09/2014
1	Angiogenesis InhibitorsIBA 09/2014
1	Methotrexate (Mexate)FDA LinkGeneric 01/2013
1	Estrogen ReceptorsIBA 01/2013
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 01/2013
1	ridaifen-BIBA 01/2013
1	Cisplatin (Platino)FDA LinkGeneric 11/2012
1	Biological ProductsIBA 12/2011
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2011
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 05/2011
1	Etoposide (VP 16)FDA LinkGeneric 05/2011
1	coenzyme Q10 (CoQ10)IBA 02/2008

Therapy/Procedure

6	Radiotherapy 10/2022 - 11/2015
4	Therapeutics 01/2018 - 01/2014
3	Drug Therapy (Chemotherapy) 01/2018 - 01/2013
1	Radioimmunotherapy 01/2022
1	Intravenous Injections 12/2018
1	Intravenous Administration 01/2014